A total amount of 3.5 million units of coagulation Factor VIII for the treatment of Hemophilia were delivered in October to El Salvador, where the product will be distributed to the patients of the Benjamin Bloom Paediatric Hospital in the capital city of San Salvador.
Standing true to its commitment to support the Italian Blood System to promote donation and ensure that the plasma collected in Italy is used ethically and rationally, Kedrion made the donation to El Salvador possible by bearing shipping costs and coordinating with the National Health Center and the Region of Emilia-Romagna for logistical aspects and customs procedures to ensure the timely delivery of the Factor VIII shipment.
This donation is part of a national agreement signed in 2013 that establishes a wider alliance between the Italian State and its Regions aimed at promoting and implementing cooperation projects to export Italian plasma-derived products for humanitarian purposes. Thanks to this agreement, in recent years over 35 million units exceeding regional needs have been donated to countries such as Afghanistan, Albania and Armenia.
